2023
DOI: 10.26226/m.641999ecb9b42e0013e592c9
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

ISID0597 - Interim results of a phase I/II, closed label, randomized pilot study for the safety and efficacy of TolaSure gel, 5% w/w targeting aggregated mutant keratin in severe epidermolysis bullosa simplex (TAMES)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles